Frequently Asked Questions Blood Pressure Procedure (RDN)

We understand that there may be many questions about the Blood Pressure Procedure. Medtronic recommends that patients interested in the procedure should consult their doctor to understand the potential benefits and risks of the procedure. Below are some answers to the most common questions about the Blood Pressure Procedure (RDN).

WHO COULD POTENTIALLY BENEFIT FROM THE RDN PROCEDURE?

Generally, the Blood Pressure Procedure is for those who have been unable to manage their blood pressure with medication or lifestyle changes alone. In consultation with your doctor you will make an educated decision on whether this procedure is right for you.

WILL THE PROCEDURE HURT?

There might be some pain or discomfort related to the delivery of energy, but pain medications will be administered as needed.

HOW LONG DOES THE PROCEDURE LAST?

The procedure typically takes about an hour to perform1,2.

WHEN CAN I GO HOME AND RESUME MY REGULAR ACTIVITIES?

Most people are able to go home within a day or two of the procedure. Your doctor will decide how long the stay at the hospital will be and when normal activities can be resumed.

WILL MY KIDNEYS WORK THE SAME AS THEY DID BEFORE THE PROCEDURE?

Please consult your healthcare professional for further direction.

WILL ANYTHING BE IMPLANTED INTO MY BODY?

The RDN procedure requires no implant to the kidneys or the arteries near the kidney.

CAN I STOP TAKING MY ANTIHYPERTENSIVE MEDICATION FOLLOWING THE PROCEDURE?

It is important to take all medications as directed by your doctor. Your doctor will advise you about any changes to your medication that may be needed.

1

Böhm et al. Safety and efficacy measurements in the Global SYMPLICITY Registry, EuroPCR 2017

2

Individual procedure times may vary.


© 2018 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. ™* Third-party brands are trademarks of their respective owners. For distribution only in markets where the Symplicity Spyral™ multi-electrode renal denervation catheter and Symplicity G3™ renal denervation RF generator have been approved. Not for distribution in the USA, Japan, France, Denmark, Spain.